La taille du marché du séquençage des miARN devrait atteindre 741,25 millions USD d’ici 2031, contre 301,52 millions USD en 2023. Le marché devrait enregistrer un TCAC de 11,90 % en 2023-2031. Les avancées technologiques dans divers types de plates-formes d’analyse de séquence et les applications croissantes des miARN stimulent la croissance du marché des tests de séquençage des miARN. L’analyse de séquence des miARN aide à la découverte de miARN non caractérisés et prend en charge l’examen des isoformes des miARN et l’étude des associations de maladies. Par conséquent, ces facteurs devraient rester les principales tendances du marché du séquençage des miARN.
Analyse du marché du séquençage des miRNA
Les miRNA sont essentiels pour identifier la progression, le développement, le pronostic, le diagnostic et la réponse au traitement des patients atteints de cancer. Peu de miRNA fonctionnent comme des suppresseurs de tumeurs, tandis que d'autres agissent comme des oncogènes. Selon un article publié dans Advanced Pharmaceutical Bulletin en juillet 2023, le miRNA agit comme une cible pour le diagnostic du cancer. Le test a été identifié comme un facteur pronostique potentiel dans les carcinomes épidermoïdes de la tête et du cou (HNSCC) grâce au profilage des miRNA. En outre, les miRNA ont également montré une application en médecine légale en raison de leurs caractéristiques telles que la stabilité et les capacités de spécificité. Par conséquent, l'adoption croissante du test de séquençage des miRNA stimule la croissance globale du marché.
Aperçu du marché du séquençage des miRNA
L'Amérique du Nord est le plus grand marché pour la croissance du marché du séquençage miRNA, les États-Unis détenant la plus grande part de marché, suivis du Canada. L'Asie-Pacifique a enregistré la croissance la plus rapide. La croissance en Amérique du Nord est caractérisée par l'application croissante du test de séquençage miRNA pour le diagnostic de plusieurs maladies potentiellement mortelles en Amérique du Nord. En outre, la demande croissante de médecine personnalisée et l'escalade des maladies chroniques et aiguës, les miRNA agissant comme un biomarqueur pour ces maladies, devraient donc augmenter la croissance du marché nord-américain du séquençage miRNA.
Personnalisez ce rapport en fonction de vos besoins
Vous bénéficierez d'une personnalisation gratuite de n'importe quel rapport, y compris de certaines parties de ce rapport, d'une analyse au niveau des pays, d'un pack de données Excel, ainsi que de superbes offres et réductions pour les start-ups et les universités.
Marché du séquençage des miRNA : perspectives stratégiques
- Obtenez les principales tendances clés du marché de ce rapport.Cet échantillon GRATUIT comprendra une analyse de données, allant des tendances du marché aux estimations et prévisions.
Facteurs moteurs et opportunités du marché des tests de séquençage MiRNA
L'adoption croissante du test de séquençage des miRNA dans le diagnostic des maladies favorise le marché
miRNAs plays an important role in the healthcare industry as miRNAs in circulation are considered promising biomarkers for the diagnosis of diseases, as well as in the prognosis. Moreover, the translation of miRNA-based therapy from a research setting to clinical application holds huge potential, which is acting as a driving factor for market growth. miRNAs can be efficiently utilized as biomarkers in diagnosing and prognosis cancers (ovarian, cervical, and breast), sepsis, cardiac diseases, and nervous system conditions.
Furthermore, miRNA assay also helps in the immune response regulation against infectious diseases, showing early changes at the onset of disease and before the pathogen detection. For instance, according to an article published in NCBI, in July 2021, COVID-19 and its early-stage diagnosis was identified with 99.9% accuracy by measuring miRNA (miR-195-5p, miR-23a-3p, and miR-423-5p). These potential applications of miRNA in diagnosing the COVID-19 virus are further propelling the market growth.
Ongoing Extensive Research on miRNA Sequencing Assay– An Opportunity in the MiRNA Sequencing Market
Extensive research related to miRNA assay has contributed to the market growth. For instance, researchers from the Université de Lyon developed BrumiR, an algorithm that can determine miRNAs and directly from sRNA-seq data. Additionally, Several academic institutes are taking the initiative to accelerate research related to miRNA sequencing and assay. For instance, the University of Manchester researchers created a database of miRNAs that have become an important resource in academia and the biotechnology industry. Such research activities pertaining to miRNA sequencing assay are boosting the market growth.
MiRNA Sequencing Market Report Segmentation Analysis
Key segments that contributed to the derivation of the MiRNA Sequencing Market analysis are product and services, type, technology, and end users.
- Based on Products and Services, the MiRNA Sequencing market is segmented into library preparation and consumables. The consumables held the largest share of the market in 2023.
- By Technology, the market is segmented into Sequencing By Synthesis, Nanopore, and Ion Semiconductor Sequencing. The Sequencing By Synthesis segment held the largest share of the market in 2023. However, the nanopore segment is expected to register the highest CAGR over the forecast period.
- By End User, the market is segmented into Research Institute, Academia, and CROs. The research institute segment held the largest share of the market in 2023.
MiRNA Sequencing Market Share Analysis by Geography
The geographic scope of the MiRNA Sequencing Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the MiRNA Sequencing Market. The market growth can be attributed to the rising adoption of miRNA sequencing assay in research studies by using miRNA as a biomarker for diseases such as cancer. Additionally, the rising prevalence of chronic diseases is a major factor in market growth. For instance, researchers from the University of Illinois at Urbana created a novel miRNA point-of-care testing for cancer diagnosis in February 2022. Similarly, according to the study published in Biosensors (Basel) in July 2023, with advantages of miRNA such as sensitivity, efficiency, cost-saving, and ease to operate, point-of-care testing (POCT) is being used widely in the detection of miRNA.
Furthermore, the presence of key market players such as Thermo Fisher Scientific, and Illumina, Inc. who are involved in increasing R&D activities for novel diseases is another contributing factor to market growth. For instance, in 2020, Illumina, Inc. invested USD 682 million in R&D to advance its sequencing technology and develop new sequence analysis technology, thereby fueling the overall market growth of North America's miRNA sequencing assay.
MiRNA Sequencing Market Regional Insights
The regional trends and factors influencing the MiRNA Sequencing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses MiRNA Sequencing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for MiRNA Sequencing Market
MiRNA Sequencing Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 301.52 Million |
| Market Size by 2031 | US$ 741.25 Million |
| Global CAGR (2023 - 2031) | 11.90% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered | By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
MiRNA Sequencing Market Players Density: Understanding Its Impact on Business Dynamics
The MiRNA Sequencing Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
La densité des acteurs du marché fait référence à la répartition des entreprises ou des sociétés opérant sur un marché ou un secteur particulier. Elle indique le nombre de concurrents (acteurs du marché) présents sur un marché donné par rapport à sa taille ou à sa valeur marchande totale.
Les principales entreprises opérant sur le marché du séquençage MiRNA sont :
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Biographie de Takara
- Laboratoires biologiques de la Nouvelle-Angleterre
- Norgen Biotek Corp
- Lexogen GmbH
Avis de non-responsabilité : les sociétés répertoriées ci-dessus ne sont pas classées dans un ordre particulier.
- Obtenez un aperçu des principaux acteurs du marché du séquençage MiRNA
Actualités et développements récents du marché du séquençage des miRNA
Le marché du séquençage MiRNA est évalué en collectant des données qualitatives et quantitatives après des recherches primaires et secondaires, qui comprennent d'importantes publications d'entreprise, des données d'association et des bases de données. Voici une liste des développements sur le marché du séquençage MiRNA :
- HTC Molecular Diagnostics Inc. a dévoilé de nouvelles fonctionnalités de sa technologie exclusive HTG EdgeSeq. L'entreprise a amélioré sa technologie et sa nouvelle harmonisation de la préparation des échantillons permet désormais le profilage des miRNA et des mRNA sans avoir besoin d'échantillons supplémentaires. Source : https://www.mordorintelligence.com/industry-reports/mirna-sequencing-and-assay-market. (Source : HTC Molecular Diagnostics, communiqué de presse/site Web de l'entreprise/bulletin d'information, avril 2022)
- Allogene Therapeutics a collaboré avec Antion Biosciences pour faire progresser le silençage génique multiplex pour le développement de produits CAR T allogéniques de nouvelle génération. Dans le cadre de cette collaboration, la technologie miRNA d'Antion (miCAR) sera utilisée comme outil supplémentaire pour améliorer l'efficacité et la sécurité des thérapies CAR T allogéniques. (Source : Biocartis, communiqué de presse/site Web de l'entreprise/bulletin d'information, janvier 2022)
- Lexogen, pionnier dans le domaine de la génomique et de la transcriptomique, est fier de présenter le kit révolutionnaire LUTHOR High-Definition Single Cell 3' mRNA-Seq, une innovation révolutionnaire qui établit de nouvelles normes dans le séquençage d'ARN unicellulaire. (Source : Lexogen, communiqué de presse/site Web de l'entreprise/bulletin d'information, janvier 2022)
Rapport sur le marché du séquençage des miRNA : couverture et livrables
Le rapport « Taille et prévisions du marché du séquençage MiRNA (2021-2031) » fournit une analyse détaillée du marché couvrant les domaines ci-dessous :
- Taille du marché et prévisions aux niveaux mondial, régional et national pour tous les segments de marché clés couverts par le périmètre
- Dynamique du marché, comme les facteurs moteurs, les contraintes et les opportunités clés
- Principales tendances futures
- Analyse détaillée des cinq forces de PEST/Porter et SWOT
- Analyse du marché mondial et régional couvrant les principales tendances du marché, les principaux acteurs, les réglementations et les développements récents du marché
- Analyse du paysage industriel et de la concurrence couvrant la concentration du marché, l'analyse de la carte thermique, les principaux acteurs et les développements récents
- Profils d'entreprise détaillés
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For